Literature DB >> 16416300

[Evidence based therapy of obesity].

H Hauner1.   

Abstract

For medical reasons, subjects with a BMI > or =30 kg/m(2) or a BMI > or =25 kg/m(2) and comorbidities such as type 2 diabetes mellitus should be considered for participation in a weight loss program. At present, there is a broad spectrum of measures to reduce body weight which have been validated in randomized controlled trials. The primary target of all intervention programs is to change lifestyle in order to establish an adequate calorie intake and an increase in physical activity. Other more aggressive options to escalate the efforts for reducing body weight include very low calorie diets, weight-lowering drugs and for the extreme forms of obesity surgical techniques. The treatment should be tailored to the "real world" and wishes of the individual patient. Patient empowerment is essential to achieve long-term self management of the weight problem. To effectively control the obesity epidemic it is of critical importance to establish preventive measures in the society. There is an urgent need to improve the structural prerequisites for a better treatment of people with overweight/obesity.

Entities:  

Mesh:

Year:  2006        PMID: 16416300     DOI: 10.1007/s00108-005-1558-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

1.  A descriptive study of individuals successful at long-term maintenance of substantial weight loss.

Authors:  M L Klem; R R Wing; M T McGuire; H M Seagle; J O Hill
Journal:  Am J Clin Nutr       Date:  1997-08       Impact factor: 7.045

2.  World Health Organization equations have shortcomings for predicting resting energy expenditure in persons from a modern, affluent population: generation of a new reference standard from a retrospective analysis of a German database of resting energy expenditure.

Authors:  Manfred J Müller; Anja Bosy-Westphal; Susanne Klaus; Georg Kreymann; Petra M Lührmann; Monika Neuhäuser-Berthold; Rudolf Noack; Karl M Pirke; Petra Platte; Oliver Selberg; Jochen Steiniger
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

3.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

4.  Long-term weight-loss maintenance: a meta-analysis of US studies.

Authors:  J W Anderson; E C Konz; R C Frederich; C L Wood
Journal:  Am J Clin Nutr       Date:  2001-11       Impact factor: 7.045

5.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial.

Authors:  Linda Stern; Nayyar Iqbal; Prakash Seshadri; Kathryn L Chicano; Denise A Daily; Joyce McGrory; Monica Williams; Edward J Gracely; Frederick F Samaha
Journal:  Ann Intern Med       Date:  2004-05-18       Impact factor: 25.391

Review 7.  Obesity in children and young people: a crisis in public health.

Authors:  T Lobstein; L Baur; R Uauy
Journal:  Obes Rev       Date:  2004-05       Impact factor: 9.213

8.  Years of life lost due to obesity.

Authors:  Kevin R Fontaine; David T Redden; Chenxi Wang; Andrew O Westfall; David B Allison
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

9.  Prevalence of overweight and obesity and trends in body mass index in German pre-school children, 1982-1997.

Authors:  H Kalies; J Lenz; R von Kries
Journal:  Int J Obes Relat Metab Disord       Date:  2002-09

Review 10.  Long-term pharmacotherapy for obesity and overweight.

Authors:  R Padwal; S K Li; D C W Lau
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  3 in total

Review 1.  [Concept of reconstructive body shaping in obesity. Evidence-based therapy algorithm].

Authors:  A Dragu; R E Horch
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

2.  Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patients.

Authors:  Uta Müller; Andrea Hämmerlein; Annette Casper; Martin Schulz
Journal:  Pharm Pract (Granada)       Date:  2006-10

3.  Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss?

Authors:  Roland Müller; Markus Laimer; Niels Hagenbuch; Kurt Laederach; Zeno Stanga
Journal:  J Eat Disord       Date:  2017-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.